These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Change in jejunal structure and function in dermatitis herpetiformis: effect of gluten-free diet and corticosteroids. Kumar P; Silk DB; Clark ML; Dawson M Gut; 1972 Oct; 13(10):847. PubMed ID: 5087099 [No Abstract] [Full Text] [Related]
43. [New aspects of vesico-bullous diseases treated by antibiocorticotherapy]. HURIEZ C; DESMONS F; AGACHE P; DUBOIS P Lille Med; 1962 Mar; 7():218-20. PubMed ID: 14450122 [No Abstract] [Full Text] [Related]
46. [Treatment of Duhring-Brocq disease with chloraminophene]. Degos R; Civatte J; Larrègue M Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):425-31. PubMed ID: 5150882 [No Abstract] [Full Text] [Related]
47. Treatment of pemphigus herpetiformis with minocycline and nicotinamide. Wu C; Zuo Y; Jin H; Chen J; Li L Chin Med J (Engl); 2014; 127(19):3514. PubMed ID: 25269925 [No Abstract] [Full Text] [Related]
49. [Experience with prophylactic medical care of vesiculobullous diseases (author's transl)]. Rozsívalová V Cesk Dermatol; 1978 Jan; 53(1):40-4. PubMed ID: 350429 [No Abstract] [Full Text] [Related]
50. [Treatment of malignant pemphigus with azathioprine]. Duperrat B; Puissant A; Chérif-Cheikh JL; David V; Audebert G Ann Med Interne (Paris); 1970 Nov; 121(11):917-9. PubMed ID: 5533590 [No Abstract] [Full Text] [Related]
51. Number II. Pemphigus vulgaris. Black M; Mignogna MD; Scully C Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101 [TBL] [Abstract][Full Text] [Related]
52. [Specificity of autoantibodies discovered in pemphigus and in the bullous variety of Duhring-Brocq disease]. Thivolet J; Beyvin AJ; André D Ann Dermatol Syphiligr (Paris); 1970; 97(5):534-41. PubMed ID: 4250902 [No Abstract] [Full Text] [Related]
53. Visken as supplementary drug in the treatment of pemphigus. Chorzelski T; Jablonska S; Maciejowska E; Blaszczyk M Dermatologica; 1975; 150(6):360-5. PubMed ID: 1201811 [TBL] [Abstract][Full Text] [Related]
54. [Herpetic superinfection of pemphigus: 6 cases]. Zouhair K; el Ouazzani T; Azzouzi S; Sqalli S; Lakhdar H Ann Dermatol Venereol; 1999 Oct; 126(10):699-702. PubMed ID: 10604008 [TBL] [Abstract][Full Text] [Related]
55. Dermatitis herpetiformis responsive to systemic corticosteroids. Lang PG J Am Acad Dermatol; 1985 Sep; 13(3):513-5. PubMed ID: 4056124 [No Abstract] [Full Text] [Related]
56. [Advantages and disadvantages of steroid therapy in skin diseases]. Steigleder GK Klin Monbl Augenheilkd; 1966; 148(6):800-10. PubMed ID: 5987288 [No Abstract] [Full Text] [Related]